The Europen Oncology Institute, IEO - Milan, presents an important project to counteract lung cancer. The new edition of the COSMOS Study is a comparative research apt to demonstrate the equivalence of lobectomy vs. segmentectomy for small lung cancers. The COSMOS II study will avail itself of double the number of patients respect the COSMOS I study. Apart from the CT low dosage scan a new early detection instrument will be employed: a new serological exam which detects specific microRNA released by the tumor cells.
The Europen Oncology Institute, IEO - Milan, presents an important project to counteract lung cancer. The new edition of the COSMOS Study is a comparative research apt to demonstrate the equivalence of lobectomy vs. segmentectomy for small lung cancers. The COSMOS II study will avail itself of double the number of patients respect the COSMOS I study. Apart from the CT low dosage scan a new early detection instrument will be employed: a new serological exam which detects specific microRNA released by the tumor cells.
presentations
Lung Cancer: the project of the IEO Institute - Milan
The microRNA markers
COSMOS II: the functional aspects
Envinronmental factors and cancer risks: the role of the epigenome
Questions and answers: 1st part
Questions and answers: 2nd part
